Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate UpdatesÂ
The Company reported net income of approximately $2,153,000.
Read More
Category: Financial
Cara Therapeutics Reports Second Quarter 2019 Financial Results
The Company received net proceeds of approximately $136.4 million after deductions.
Read More
WeedMD Reports Preliminary Q2 Net Revenues of $8 Million and Confirms Earnings Call on August 29, 2019
WeedMD increased its net revenues quarter-over-quarter by more than 140% to $8 million.
Read More
GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2019
Epidiolex in the U.S. yielded Q2 net sales of $68.4 million.
Read More
CV Sciences, Inc. Reports Second Quarter 2019 Financial Results
Record quarterly revenue Increased retail distribution by over 1,200 stores.
Read MoreGET LISTED
